Galactic
Main objective:
In this study, an inhaled investigational is taken at daily over 52 weeks to evaluate the efficacy and safety, in participants who have Idiopathic Pulmonary Fibrosis.
Who are we looking for?
- Established diagnosis of Idiopathic Pulmonary Fibrosis
- Age: 40+
- Additional criteria not listed here
What’s provided for duration of study:
- Study medication
- Safety testing
- Modest payments for each visit completed
If you would like additional information, please send us an email or give us a call!